The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of cisplatin/gemcitabine or carboplatin/gemcitabine on efficacy, toxicity, and quality of life from the randomized DISCUS trial.
 
Syed Hussain
Honoraria - Merck; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Merck; Pfizer; Roche
Research Funding - Boehringer Ingelheim; Janssen-Cilag; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bayer; Janssen-Cilag; Merck; MSD Oncology; Pfizer; Roche
 
Iciar García Carbonero
No Relationships to Disclose
 
Javier Molina Cerrillo
Consulting or Advisory Role - Adium Pharma; Advanced Accelerator Applications; Astellas Pharma; BMS; Eisai; Ipsen; Janssen; MSD; Pfizer; Sanofi
Speakers' Bureau - BMS; Ipsen; Pfizer
Research Funding - Ipsen (Inst); Janssen (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Ipsen
 
Javier Puente
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma; Merck (Inst); Pfizer; Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Janssen-Cilag; Merck Serono; MSD Oncology; Pfizer; Roche
 
Pablo Borrega
No Relationships to Disclose
 
Jahangeer Malik
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Merck
Consulting or Advisory Role - Eisai; Ipsen
Speakers' Bureau - Bayer; Bristol-Myers Squibb/Pfizer; Eisai
Travel, Accommodations, Expenses - Eisai; Novartis
 
Louis-Marie Dourthe
Honoraria - AstraZeneca; Bayer; Janssen; Merck Serono; Pfizer
Speakers' Bureau - Bayer; Janssen; Merck Serono; Pfizer
Travel, Accommodations, Expenses - Bayer
 
Robert Jones
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Elsevier; Ipsen; Janssen; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche/Genentech; WebMD
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Celgene; IPSEN; Janssen; Merck Serono; MSD Oncology; Pfizer
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen; Merck Serono; MSD; Pfizer
 
Daniel Castellano
No Relationships to Disclose
 
Yohann Loriot
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Janssen; Loxo/Lilly; Merck KGaA; MSD Oncology; MSD Oncology (Inst); Pfizer (Inst); Pfizer/EMD Serono; Roche; Roche (Inst); Seagen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BMS (Inst); Exelixis (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Tyra Biosciences (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen
 
Francesca Jackson-Spence
Honoraria - MSD
Travel, Accommodations, Expenses - EUSA Pharma; Merck
 
Garima Priyadarshini
No Relationships to Disclose
 
Fahmida Jamal
No Relationships to Disclose
 
Elizabeth Nally
No Relationships to Disclose
 
Sara Coca Membribes
No Relationships to Disclose
 
Charlotte Ackerman
No Relationships to Disclose
 
Enrique Grande
Employment - Quironsalud
Stock and Other Ownership Interests - Bicycle Therapeutics; PharmaMar
Honoraria - Abbott/AbbVie; Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; AVEO; Bristol-Myers Squibb; Dr. Reddy's Laboratories; Eisai; Eusa Pharma; EUSA Pharma; GlaxoSmithKline; IPSEN; Janssen-Cilag; Lilly; Merck KGaA; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Abbvie; AVEO; Bristol-Myers Squibb; Gilead Sciences; Ipsen; MSD; Pfizer; Roche; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ipsen (Inst); Lexicon (Inst); Merck KGaA (Inst); Molecular Templates (Inst); Pfizer (Inst); Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Pfizer; Roche/Genentech
 
Thomas Powles
Honoraria - Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson/Janssen; MashupMD; Merck; Merck Serono; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson; MashupMD; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Johnson & Johnson; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD; Pfizer; Roche
 
Miguel Climent Duran
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai Europe; Ipsen; Janssen; Merck; MSD Oncology; Novartis; Pfizer; RECORDATI; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Janssen Oncology; Janssen-Cilag; Merck; MSD Oncology; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen; Merck; MSD Oncology; Pfizer; Roche